Dr Reddys Laboratories Share Price
CMP as on 02-Mar-21 15:59
₹ 4,404.70Open
₹ 4,473.40Turnover (lac)
₹ 80,944Prev. Close
₹ 4,453.40Day's Vol (shares)
₹ 18,37,678CMP as on02-Mar-21 15:55
₹ 4,406.20Open
₹ 4,472.00Turnover (lac)
₹ 2,203Prev. Close
₹ 4,453.30Day's Vol (shares)
₹ 47,382CMP as on 02-Mar-21 0:00
₹ 4,439.00Open
₹ 4,476.55Open Interest(Contracts)
₹ 37,05,375VWAP
₹ 4,443.85Day's Vol (shares)
₹ 17,72,875News
-
Nifty Pharma rallies over 1%; Lupin and Cipla led the pack, Sun Pharma adds sign
13:45 IST, Mar 02DR Reddys Lab was the lone laggard in the sector, shedding ~1% at Rs4,410.95 per piece.
-
Dr Reddys Laboratories allots 2,253 equity shares under ESOP
18:51 IST, Mar 01Dr Reddys Laboratories allots 2,253 equity shares under ESOP
-
Bloody Friday! Sensex nosedives 1,565 pts, Nifty near 14,650; Banks underperform
11:40 IST, Feb 26Banking stocks were the worst hit along with substantial downside in IT, auto and financial stocks.
-
Nifty closes lower; Pharma stocks underperformed
15:38 IST, Feb 22Nifty Pharma index closed ~3% lower with the stocks like Aurobindo Pharma, Sun Pharma, Lupin & Dr Reddys adding fresh short positio
-
Dr Reddys launches Lansoprazole DR Orally Disintegrating Tablets in U.S.
14:38 IST, Feb 22Dr Reddys launches Lansoprazole DR Orally Disintegrating Tablets in U.S.
-
Dr Reddys Lab launches lansoprazole tablets in US
11:55 IST, Feb 22The drug major on Monday announced the launch of lansoprazole DR orally disintegrating tablets in the US market.
-
USFDA allows Dr. Reddy's to market Lansoprazole DR Orally Disintegrating Tablets
11:48 IST, Feb 22Dr. Reddys Lansoprazole DR Orally Disintegrating Tablets are available in 15 mg and 30 mg tablets in unit-dose packages of 100 (10 x 10
-
Dr Reddy's Lab initiates process with DCGI for emergency use authorisation of Sp
17:01 IST, Feb 19Dr Reddy's will present the safety profile of the phase 2 study, and interim data of the phase 3 study, which is expected to complete b
-
Nifty closed lower; Banking stocks underperformed
15:49 IST, Feb 19Market breadth ended in the favour of the declines with the advance/decline ratio closing at 1:2x.
-
Dr Reddys Lab gains on seeking emergency use authorisation for Sputnik V in Indi
15:21 IST, Feb 19Dr Reddys Laboratories rose 1.12% to Rs 4669.40 after the company announced that it has initiated process for emergency use authorizati
